4 Firms Will Seek Up To $21M For Bioverativ Suit Settlement
Attorneys representing stockholders of Bioverativ Inc. will seek an up to $21 million award for their work brokering an $84 million deal to partially settle a class challenge in Delaware Chancery...To view the full article, register now.
Already a subscriber? Click here to view full article